Isolation of other micro‐organisms from the respiratory tract: number of positive cultures per patient year · children and adolescents with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Eradication of P aeruginosa from the respiratory tract: number of participants testing negative for P aeruginosa at 3 months and remaining free until 15 months · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 % predicted · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
FVC · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
Mean weight‐for‐age z‐score · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
Frequency of infective pulmonary exacerbations: number of participants experiencing an exacerbation · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
Intravenous ceftazidime with tobramycin showed no clear difference in frequency of infective pulmonary exacerbations: number of… compared with oral ciprofloxacin (high certainty).
1 finding from 1 review
Isolation of other micro‐organisms from the respiratory tract: number of participants isolating other micro‐organisms within the 15‐month · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
Intravenous ceftazidime with tobramycin leads to higher isolation of other micro‐organisms from the respiratory tract:… compared with oral ciprofloxacin (high certainty).
1 finding from 1 review
Eradication of P aeruginosa from the respiratory tract: time to next isolation of P aeruginosa from BAL, sputum or oropharyngeal cultures · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 % predicted · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
Resolution of symptoms post‐treatment (ITT analysis) · group A streptococcal pharyngitis
Cephalosporins showed no clear difference in resolution of symptoms post‐treatment (ITT analysis) compared with penicillin (low certainty).
1 finding from 1 review
Clinical cure (bacteriological per protocol analysis) · group A streptococcal pharyngitis
It is very uncertain whether azithromycin changes clinical cure (bacteriological per protocol analysis) compared with amoxicillin (very low certainty).
1 finding from 1 review
Relapse · group A streptococcal pharyngitis
It is very uncertain whether azithromycin changes relapse (ITT analysis) compared with amoxicillin (very low certainty).
1 finding from 1 review
Relapse (bacteriological per protocol analysis) · group A streptococcal pharyngitis
It is very uncertain whether azithromycin changes relapse (bacteriological per protocol analysis) compared with amoxicillin (very low certainty).
1 finding from 1 review
Adverse events (ITT analysis) · group A streptococcal pharyngitis
It is very uncertain whether azithromycin changes adverse events (ITT analysis) compared with amoxicillin (very low certainty).
1 finding from 1 review
Resolution of symptoms post‐treatment (ITT analysis) · group A streptococcal pharyngitis
Carbacephem may leads to lower resolution of symptoms post‐treatment (ITT analysis) compared with penicillin (low certainty).
1 finding from 1 review
Resolution of symptoms post‐treatment (evaluable participants) · group A streptococcal pharyngitis
Carbacephem showed no clear difference in resolution of symptoms post‐treatment (evaluable participants) compared with penicillin (low certainty).
1 finding from 1 review
Relapse · group A streptococcal pharyngitis
Carbacephem showed no clear difference in incidence of relapse (evaluable participants) compared with penicillin (low certainty).
1 finding from 1 review
Adverse events (ITT analysis) · group A streptococcal pharyngitis
Carbacephem showed no clear difference in adverse events (ITT analysis) compared with penicillin (low certainty).
1 finding from 1 review
Resolution of symptoms post‐treatment (evaluable participants) · group A streptococcal pharyngitis
It is very uncertain whether cephalosporins changes resolution of symptoms post‐treatment (evaluable participants) compared with penicillin (very low certainty).
1 finding from 1 review
Relapse · group A streptococcal pharyngitis
Cephalosporins may leads to lower incidence of relapse (evaluable participants) compared with penicillin (low certainty).
1 finding from 1 review